Sakamuro D, Elliott K J, Wechsler-Reya R, Prendergast G C
Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
Nat Genet. 1996 Sep;14(1):69-77. doi: 10.1038/ng0996-69.
BIN1 is a novel protein that interacts with the functionally critical Myc box regions at the N terminus of the MYC oncoprotein. BIN1 is structurally related to amphiphysin, a breast cancer-associated autoimmune antigen, and RVS167, a negative regulator of the yeast cell cycle, suggesting roles in malignancy and cell cycle control. Consistent with this likelihood, BIN1 inhibited malignant cell transformation by MYC. Although BIN1 is expressed in many normal cells, its levels were greatly reduced or undetectable in 14/27 carcinoma cell lines and 3/6 primary breast tumours. Deficits were functionally significant because ectopic expression of BIN1 inhibited the growth of tumour cells lacking endogenous message. We conclude that BIN1 is an MYC-interacting protein with features of a tumour suppressor.
BIN1是一种新型蛋白质,它与MYC癌蛋白N端功能关键的Myc盒区域相互作用。BIN1在结构上与乳腺癌相关自身免疫抗原 amphiphysin以及酵母细胞周期负调节因子RVS167相关,提示其在恶性肿瘤和细胞周期调控中发挥作用。与此可能性相符的是,BIN1抑制了MYC介导的恶性细胞转化。尽管BIN1在许多正常细胞中表达,但其水平在27个癌细胞系中的14个以及6个原发性乳腺肿瘤中的3个中显著降低或无法检测到。这些缺陷在功能上具有重要意义,因为BIN1的异位表达抑制了缺乏内源性信使的肿瘤细胞的生长。我们得出结论,BIN1是一种与MYC相互作用的蛋白质,具有肿瘤抑制因子的特征。